Key result
Disruption of MK2 in mice prevented myofibroblast formation but exacerbated bleomycin-induced pulmonary fibrosis, resulting in a 180% increase in collagen deposition compared to a 77% increase in wild-type mice.
Why the study?
Does MK2 disruption prevent myofibroblast formation and ameliorate pulmonary fibrosis in a mouse model?
Does MK2 disruption prevent myofibroblast formation and ameliorate pulmonary fibrosis in a mouse model?
Inhibiting MK2-mediated myofibroblast differentiation exacerbates rather than protects against pulmonary fibrosis in a mouse model.
Answers are grounded in this paper and cite their sources.
Inhibiting MK2 exacerbates fibrosis despite blocking myofibroblasts; leaves open its therapeutic targeting in pulmonary fibrosis.
Fibroblasts play a major role in tissue repair and remodeling. Their differentiation into myofibroblasts, marked by increased expression of smooth muscle-specific alpha-actin (alpha-SMA), is believed to be important in wound healing and fibrosis. We have recently described a role for MK2 in this phenotypic differentiation in culture. In this article, we demonstrate that MK2 also regulates myofibroblasts in vivo. Disruption of MK2 in mice prevented myofibroblast formation in a model of pulmonary fibrosis. However, MK2 disruption and consequent lack of myofibroblast formation exacerbated fibrosis rather than ameliorated it as previously postulated. When mice lacking MK2 (MK2-/-) were exposed to bleomycin, more collagen accumulated and more fibroblasts populated fibrotic regions in their lungs than in similarly treated wild-type mice. While there were many vimentin-positive cells in the bleomycin-treated MK2-/- mouse lungs, few alpha-SMA-positive cells were observed in these lungs compared with wild-type mouse lungs. siRNA against MK2 reduced alpha-SMA expression in wild-type mouse embryonic fibroblasts (MEF), consistent with its suppression in MK2-/- MEF. On the other hand expressing constitutively active MK2 in MK2-/- MEF significantly increased alpha-SMA expression. MK2-/-MEF proliferated at a faster rate and produced more collagen; however, they migrated at a slower rate than wild-type MEF. Overexpressing phosphomimicking HSP27, a target of MK2, did not reverse the effect of MK2 disruption on fibroblast migration. MK2 disruption did not affect Smad2 activation by transforming growth factor-beta. Thus, MK2 appears to mediate myofibroblast differentiation, and inhibiting that differentiation might contribute to fibrosis rather than protect against it.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2007) studied Pulmonary fibrosis (n=27). MK2 disruption (knockout) vs. Wild-type was evaluated on Acid-soluble lung collagen content increase in response to bleomycin (p=<0.05). Disruption of MK2 in mice prevented myofibroblast formation but exacerbated bleomycin-induced pulmonary fibrosis, resulting in a 180% increase in collagen deposition compared to a 77% increase in wild-type mice.
Synapse has enriched 10 related papers. Consider them for comparative context: